APD Air Products & Chemicals, Inc.
Industrial Inorganic Chemicals · NYSE · SEC CIK 2969 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.5%
TTM net income YoY-103.1%
TTM EPS YoY-103.0%
Revenue 3-yr CAGR-1.0%
Net income 3-yr CAGR—
Margins
Gross margin32.1%
Operating margin-4.7%
Net margin-0.4%
FCF margin-2.4%
EBITDA margin7.5%
Returns
ROE-0.3%
ROA-0.1%
ROIC (approx.)-3.6%
Asset turnover0.31x
Leverage & solvency
Liabilities / assets59.0%
Debt / equity0.00x
Current ratio1.08x
Interest coverage-2.68x
Cash quality & payout
Operating cash flow / net income-96.63x
Accruals ratio-11.2%
Payout ratio—
Capex / revenue38.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-06-30 | 2026Q22026-03-31 | 2026Q12025-12-31 | 2025Q4*2025-09-30 | 2025Q32025-06-30 | 2025Q22025-03-31 | 2025Q12024-12-31 | 2024Q4*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.16B | $3.17B | $3.10B | $3.17B | $3.02B | $2.92B | $2.93B | $3.19B |
| Cost of revenue | $2.12B | $2.18B | $2.11B | $2.15B | $2.04B | $2.05B | $2.02B | $2.10B |
| Gross profit | $1.04B | $987.40M | $995.00M | $1.02B | $982.60M | $862.30M | $915.00M | $1.08B |
| R&D expense | $21.50M | $21.60M | $20.40M | $27.30M | $24.10M | $22.90M | $22.00M | $22.10M |
| SG&A expense | $219.10M | $227.20M | $228.70M | $219.10M | $222.60M | $222.00M | $242.40M | $228.00M |
| Operating income | -$2.10B | $752.70M | $734.50M | $16.80M | $790.60M | -$2.33B | $643.60M | $2.42B |
| Interest expense | $49.40M | $49.50M | $54.50M | $67.80M | $61.40M | $42.20M | $42.60M | $49.70M |
| Pretax income | -$1.94B | $883.50M | $850.80M | $121.30M | $890.80M | -$2.24B | $790.50M | $2.50B |
| Income tax | -$515.40M | $158.70M | $159.40M | $111.20M | $159.60M | -$505.80M | $140.70M | $538.40M |
| Net income | -$1.44B | $710.40M | $678.20M | $4.90M | $713.80M | -$1.73B | $617.40M | $1.95B |
| EBITDA | -$1.71B | $1.13B | $1.11B | $429.60M | $1.19B | -$1.94B | $1.01B | $2.81B |
| EPS (basic) | -6.47 | 3.19 | 3.04 | — | 3.20 | -7.77 | 2.77 | — |
| EPS (diluted) | -6.47 | 3.19 | 3.04 | — | 3.20 | -7.77 | 2.77 | — |
| Dividends declared per share | 1.81 | 1.81 | 1.79 | 1.79 | 1.79 | 1.79 | 1.77 | 1.77 |
| Weighted avg. shares (diluted) | 222.80M | 222.90M | 222.90M | — | 222.90M | 222.80M | 222.90M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $980.50M | $951.00M | $1.03B | $1.86B | $2.32B | $1.49B | $1.85B | $2.98B |
| Short-term investments | — | — | — | $0 | $0 | $111.40M | $117.50M | $5.00M |
| Receivables | $1.88B | $1.94B | $1.89B | $1.90B | $1.94B | $1.85B | $1.81B | $1.82B |
| Inventory | $751.60M | $767.90M | $788.10M | $776.50M | $797.70M | $769.70M | $739.00M | $766.00M |
| Current assets | $4.96B | $5.01B | $5.10B | $5.83B | $6.15B | $5.19B | $5.35B | $6.36B |
| PP&E, net | $25.00B | $26.69B | $26.14B | $25.34B | $25.64B | $24.03B | $24.73B | $23.37B |
| Goodwill | $957.40M | $958.70M | $971.50M | $963.90M | $969.70M | $887.10M | $866.50M | $905.10M |
| Intangibles | $278.40M | $283.50M | $294.40M | $293.50M | $302.40M | $281.60M | $287.50M | $311.60M |
| Total assets | $40.45B | $41.64B | $41.24B | $41.06B | $41.66B | $38.87B | $40.02B | $39.57B |
| Current liabilities | $4.58B | $3.51B | $3.50B | $4.22B | $4.76B | $5.21B | $4.81B | $4.18B |
| Short-term debt | $126.70M | $314.40M | $66.70M | $34.70M | $536.20M | $773.20M | $68.20M | $83.50M |
| Total liabilities | $23.85B | $23.49B | $23.40B | $23.71B | $23.89B | $22.09B | $21.28B | $20.90B |
| Shareholders' equity | $13.88B | $15.65B | $15.41B | $15.02B | $15.54B | $14.70B | $16.69B | $17.04B |
| Shares outstanding | — | — | — | 222.59M | — | — | — | 222.37M |
| Cash flow statement | ||||||||
| Operating cash flow | $1.31B | $1.10B | $900.70M | $1.26B | $855.80M | $328.10M | $811.70M | $957.00M |
| Capital expenditure | $995.70M | $1.11B | $1.25B | $1.52B | $1.50B | $1.89B | $2.12B | $2.08B |
| Free cash flow | $309.50M | -$3.90M | -$350.50M | -$256.50M | -$640.00M | -$1.56B | -$1.31B | -$1.12B |
| Investing cash flow | -$992.70M | -$1.08B | -$1.24B | -$1.49B | -$1.26B | -$2.24B | -$2.18B | -$145.40M |
| Financing cash flow | -$285.30M | -$101.00M | -$490.10M | -$239.10M | $1.21B | $1.55B | $274.20M | -$232.30M |
| Depreciation & amortization | $385.40M | $375.00M | $370.70M | $412.80M | $401.00M | $383.60M | $366.80M | $380.80M |
| Stock-based compensation | $12.30M | $16.00M | $10.60M | $10.70M | $11.00M | $38.30M | $16.40M | $15.60M |
| Dividends paid | $403.00M | $398.60M | $398.40M | $398.40M | $398.30M | $393.80M | $393.60M | $393.50M |
Free plan shows the latest 8 periods; Pro shows all 73 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.